Nonverbal Communication: Clinical Trials

5 trials for Nonverbal Communication, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5
Phase 21Completed 1

Follow Nonverbal Communication: new trials by email Literature Review of Nonverbal Communication trials Research Report on Nonverbal Communication

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Acupuncture in Infantile Colic - a Three Armed Randomized Multi Center Trial (ACU-COL)
Acupuncture - Infantile Colic
Phase 2 / Phase 3CompletedLund University1472013-01-012016-06-28
Lactobacillus Reuteri for the Treatment of Infantile Colic:
Lactobacillus reuteri (DSM 17938) - Infantile Colic, Crying
Phase 3CompletedMedical University of Warsaw802009-12-012012-06-05
Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis
Masitinib, Placebo, Best Supportive Care - Indolent Systemic Mastocytosis
Phase 3CompletedAB Science1352008-12-012019-12-03
Gabapentin for the Treatment of Hot Flashes in Menopausal Women
gabapentin - Hot Flashes, Menopause
Phase 3CompletedNorth Toronto Primary Care Research Network2002004-03-012011-05-23
Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients
AVP-923 - Multiple Sclerosis
Phase 3CompletedAvanir Pharmaceuticals962002-12-012016-07-14

Narrower conditions

Crying (3)  ·  Blushing (2)  ·  Colic (2)  ·  Hot Flashes (1)  ·  Laughter (1)  ·  Mastocytosis (1)  ·  Mastocytosis, Systemic (1)  ·  Multiple Sclerosis (1)  ·  Piebaldism (1)  ·  Pruritus (1)

Broader conditions

Behavior (5)  ·  Communication (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Immune System Diseases (2)  ·  Infant, Newborn, Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Albinism (1)  ·  Amino Acid Metabolism, Inborn Errors (1)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Eye Diseases, Hereditary (1)

Interventions

Acupuncture Therapy (1)  ·  Gabapentin (1)  ·  dextromethorphan - quinidine combination (1)  ·  masitinib (1)

Sponsors

AB Science (1)  ·  Avanir Pharmaceuticals (1)  ·  Lund University (1)  ·  Medical University of Warsaw (1)  ·  North Toronto Primary Care Research Network (1)

Countries

United States (2)  ·  Canada (1)  ·  France (1)  ·  Poland (1)  ·  Sweden (1)

Top investigators

Debra Butt, MSc MD CCFP (1)  ·  Kajsa Landgren, PhD (1)  ·  Olivier Lortholary, MD, PhD (1)

Results publications

PMID 16634036, PMID 22981952, PMID 26370560, PMID 28069279, PMID 28093383, PMID 32375501